YorkBridge Wealth Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $224K | Sell |
774
-2
| -0.3% | -$578 | 0.06% | 236 |
|
|
2022
Q3 | $225K | Sell |
776
-2
| -0.3% | -$580 | 0.06% | 249 |
|
|
2022
Q2 | $219K | Sell |
778
-6
| -0.8% | -$1.69K | 0.06% | 257 |
|
|
2022
Q1 | $205K | Buy |
+784
| New | +$205K | 0.05% | 280 |
|
|
2021
Q3 | – | Sell |
-1,023
| Closed | -$206K | – | 264 |
|
|
2021
Q2 | $206K | Buy |
1,023
+27
| +3% | +$5.44K | 0.05% | 240 |
|
|
2021
Q1 | $214K | Buy |
996
+39
| +4% | +$8.38K | 0.06% | 235 |
|
|
2020
Q4 | $226K | Sell |
957
-46
| -5% | -$10.9K | 0.08% | 190 |
|
|
2020
Q3 | $273K | Buy |
1,003
+16
| +2% | +$4.36K | 0.11% | 146 |
|
|
2020
Q2 | $287K | Sell |
987
-7
| -0.7% | -$2.04K | 0.13% | 137 |
|
|
2020
Q1 | $237K | Sell |
994
-185
| -16% | -$44.1K | 0.15% | 134 |
|
|
2019
Q4 | $258K | Sell |
1,179
-36
| -3% | -$7.88K | 0.12% | 157 |
|
|
2019
Q3 | $206K | Sell |
1,215
-63
| -5% | -$10.7K | 0.1% | 168 |
|
|
2019
Q2 | $234K | Buy |
1,278
+51
| +4% | +$9.34K | 0.1% | 161 |
|
|
2019
Q1 | $226K | Sell |
1,227
-6
| -0.5% | -$1.11K | 0.1% | 155 |
|
|
2018
Q4 | $204K | Buy |
1,233
+50
| +4% | +$8.27K | 0.11% | 148 |
|
|
2018
Q3 | $227K | Buy |
1,183
+50
| +4% | +$9.59K | 0.1% | 160 |
|
|
2018
Q2 | $193K | Buy |
1,133
+132
| +13% | +$22.5K | 0.08% | 178 |
|
|
2018
Q1 | $162K | Sell |
1,001
-27
| -3% | -$4.37K | 0.07% | 207 |
|
|
2017
Q4 | $159K | Sell |
1,028
-233
| -18% | -$36K | 0.08% | 207 |
|
|
2017
Q3 | $192K | Sell |
1,261
-150
| -11% | -$22.8K | 0.1% | 178 |
|
|
2017
Q2 | $181K | Sell |
1,411
-64
| -4% | -$8.21K | 0.1% | 182 |
|
|
2017
Q1 | $175K | Sell |
1,475
-124
| -8% | -$14.7K | 0.09% | 182 |
|
|
2016
Q4 | $140K | Buy |
+1,599
| New | +$140K | 0.08% | 194 |
|